SAN ANTONIO - A new study implicates 160 genes in brain shrinkage seen on MRIs of 45,000 healthy adults. The shrinkage is in the cortex, the dimply outer layer of the brain that gives rise to thinking, awareness and action, and largely consists of gray matter.
The study, published Sept. 22 in the journal Nature Communications, examined 34 regions of the cortex in a discovery group of 22,894 individuals, then confirmed the findings in a replication group of 22,635 individuals.
“It is important to understand the biology of multiple regions of the cortex because each is affected differently in the various types of neurodegeneration including Alzheimer’s disease,” said Sudha Seshadri, MD, senior study author from The University of Texas Health Science Center at San Antonio (UT Health San Antonio).
“We asked, ‘What are the genes that seem to determine the thickness, area and volume of gray matter in these regions?’” Dr. Seshadri, who directs the university’s Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, added. “And the genes we found point to interesting pathways that seem to be involved in brain development, vascular and neurodegenerative disease, and some psychiatric conditions.”
Brain shrinkage occurs with normal aging, but the pattern of shrinkage in healthy individuals differs from the pattern in those who develop disease. The genes represent new targets of study for development of drugs to intervene before the onset of clinical symptoms, Dr. Seshadri said.
“This is a very rich resource, and it will be mined for many years to understand the different associations we are seeing,” Dr. Seshadri said. “We are excited to share it with the world.”
Large study samples
Claudia Satizabal, PhD, of the Biggs Institute and Department of Population Health Sciences in UT Health San Antonio’s Joe R. and Teresa Lozano Long School of Medicine, is one of the lead epidemiologists for the research. “This study has considerable statistical power,” Dr. Satizabal said. “Because the results from the first sample were replicated in a second equally large sample, it is less likely that the results are purely due to chance.”
Dr. Satizabal and Dr. Seshadri previously published a study on the volumes of structures deep within the brain that determine subconscious needs such as appetite and sleep. In this new paper the team examined the brain surface, which is important for conscious thinking abilities.
The discovery sample is from 20 study populations within the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium and the UK Biobank. The replication sample is from the Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) Consortium.
Study limitations included the variability of instruments to image the brain among cohorts due to different scanners, field strengths and analysis software. The sample is composed mainly of European ancestry.
“We seek to add other ethnicities to the CHARGE cohorts, including our Hispanic population of South Texas,” Dr. Seshadri said.
Genetic correlations and genome-wide associations of cortical structure in general population samples of 22,824 adults
Authors worldwide, including from the Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San Antonio: Habil Zare, PhD; Claudia L. Satizabal, PhD, and Sudha Seshadri, MD (Dr. Seshadri is faculty in the Department of Neurology. Dr. Zare is with the Glenn Biggs Institute and the Department of Cell Systems and Anatomy.)
First published: Sept. 22, 2020, Nature Communications
The Long School of Medicine at The University of Texas Health Science Center at San Antonio is named for Texas philanthropists Joe R. and Teresa Lozano Long. The school is the largest educator of physicians in South Texas, many of whom remain in San Antonio and the region to practice medicine. The school teaches more than 900 students and trains 800 residents each year. As a beacon of multicultural sensitivity, the school annually exceeds the national medical school average of Hispanic students enrolled. The school’s clinical practice is the largest multidisciplinary medical group in South Texas with 850 physicians in more than 100 specialties. The school has a highly productive research enterprise where world leaders in Alzheimer’s disease, diabetes, cancer, aging, heart disease, kidney disease and many other fields are translating molecular discoveries into new therapies. The Long School of Medicine is home to a National Cancer Institute-designated cancer center known for prolific clinical trials and drug development programs, as well as a world-renowned center for aging and related diseases.
The University of Texas Health Science Center at San Antonio, also referred to as UT Health San Antonio, is one of the country’s leading health sciences universities and is designated as a Hispanic-Serving Institution by the U.S. Department of Education. With missions of teaching, research, patient care and community engagement, its schools of medicine, nursing, dentistry, health professions and graduate biomedical sciences have graduated more than 37,000 alumni who are leading change, advancing their fields, and renewing hope for patients and their families throughout South Texas and the world. To learn about the many ways “We make lives better®,” visit www.uthscsa.edu.
To see how we are battling COVID-19, read inspiring stories on Impact.